Colgate-Palmolive Co. (0P59)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 92.17 |
|---|---|
| 52-week range | 49.36 – 100.00 |
| Return, 1 month / 3 months | +7.4% / +0.5% |
| Return, 1 year / 3 years | +20.8% / +36.0% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 83.4% |
| Worst drawdown (1 year) | -49.8% |
| Average daily value traded | 0.33M USD |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Colgate-Palmolive is a consumer products company based in the United States that makes and markets everyday household goods. Its oral care range includes toothpaste, toothbrushes and mouthwash sold under the Colgate name, while its personal care and home care lines cover soaps, deodorants, shampoos and surface cleaners under brands such as Palmolive and Softsoap. The company also produces pet food through its Hill's business. Its customers are households around the world, reached through supermarkets, pharmacies and other retailers.
On this site Colgate-Palmolive Co. appears as a stock on the London Stock Exchange (UK), code 0P59, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Colgate-Palmolive Co. (0P59) trades on the London Stock Exchange in UK. It last closed at USD 92.17 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,368 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.8% and over the last three months it rose 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.9% | ||
| From 52-week high | -6.9% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.5% | ||
| 6-month return | 10.4% | ||
| 12-month return, skipping the last month | 12.6% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 83.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.8% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.33M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | +7.4% |
| 3 months | +0.5% |
| 6 months | +10.4% |
| 1 year | +20.8% |
| 3 years | +36.0% |
| 5 years | +36.1% |
Signals
| 50-day / 200-day average | 89.42 / 88.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jul 2026 | USD 0.5300 |
| 17 Apr 2026 | USD 0.5300 |
| 20 Jan 2026 | USD 0.5200 |
| 16 Oct 2025 | USD 0.5200 |
| 17 Jul 2025 | USD 0.5200 |
| 16 Apr 2025 | USD 0.5200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.